OCULUS INNOVATIVE SCIENCES, INC.

Company

Sonoma Pharmaceuticals, Inc.

Filed

November 21, 2014

Accession Number

0001019687-14-004450

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →